tiprankstipranks
Instil Bio Secures Loan to Refinance Facility
Company Announcements

Instil Bio Secures Loan to Refinance Facility

Story Highlights

Don't Miss Our Christmas Offers:

Instil Bio ( (TIL) ) has shared an announcement.

Instil Bio, Inc., through its subsidiary Complex Therapeutics LLC, has secured an $85.6 million term loan from Midland National Life Insurance Company to refinance loans associated with its Tarzana, California facility. The loan agreement includes a two-year term with a one-year extension option, interest-only payments, and various conditions and covenants, reflecting a strategic move to streamline financial obligations and reinforce property security, which could impact its overall financial stability and operational focus.

More about Instil Bio

Instil Bio, Inc. operates in the biotechnology industry, focusing on the development of innovative therapies. It is involved in the construction and development of facilities, such as the one in Tarzana, California, through its subsidiary, Complex Therapeutics LLC.

YTD Price Performance: 170.47%

Average Trading Volume: 141,928

Technical Sentiment Consensus Rating: Buy

Current Market Cap: $134.5M

Learn more about TIL stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyInstil Bio price target lowered to $110 from $120 at H.C. Wainwright
TheFlyInstil Bio files $200M mixed securities shelf
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App